Kidney Stone Extraction Balloon Market By Product Type (Dual-Lumen / Multi-Lumen Extraction Balloons, Single-Lumen Balloon Systems, Double-Balloon and Specialty Occlusion Systems); By Surgical Application (Ureteroscopy [URS] and Retrograde Intrarenal Surgery [RIRS], Percutaneous Nephrolithotomy [PCNL], Other Stone Management Procedures); By Balloon Material (Silicone-Based Extraction Balloons, Polyurethane and Nylon Balloons, Other Materials); By End User (Hospitals, Ambulatory Surgical Centers [ASCs], Specialty Urology Clinics); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2026–2032

Kidney Stone Extraction Balloons Ride the Endourology Shift – (Updated On: 28th-Sep-2026)

The Global Kidney Stone Extraction Balloon Market was valued at USD 450 million in 2025 and is projected to reach USD 690 million by 2032, expanding at a CAGR of 6.25% during 2026–2032, according to Strategic Market Research.

 

Kidney Stone Extraction Balloon Market refers to the global market for specialized inflatable balloon catheter devices used by urologists during kidney stone removal procedures. A kidney stone extraction balloon typically consists of a thin catheter with an expandable balloon tip. During procedures such as ureteroscopy (URS), retrograde intrarenal surgery (RIRS), and percutaneous nephrolithotomy (PCNL), the balloon is positioned near the stone site and inflated using fluid or contrast media.

 

An estimated 16 million kidney stone removal procedures were performed globally in 2025, creating a substantial addressable base for extraction devices. Approximately 9.6 million procedures were associated with ureteroscopy and RIRS, the procedural categories most closely linked with endoscopic stone-retrieval accessories. Of this pool, an estimated 2.44 million procedures represented direct balloon-addressable applications, supporting annual consumption of approximately 2.5 million kidney stone extraction balloon units. This procedure-to-unit relationship makes intervention volumes a more direct revenue indicator for suppliers than kidney stone prevalence alone.

 

Boston Scientific Corporation remains an important participant in the stone-management device market through products such as the Extractor™ Pro Retrieval Balloon Catheter. Its adjustable balloon sizing and catheter design allow physicians to use one device across different anatomical conditions and stone-removal requirements. Commercially, this type of multi-size functionality can reduce the need to stock several balloon variants while strengthening supplier positioning with hospitals seeking broader procedural coverage from a smaller device inventory.

 

Overall, the Kidney Stone Extraction Balloon Market is transitioning from a niche procedural accessory market into an important component of modern endourology. Growing stone incidence, expanding minimally invasive treatment adoption, rising outpatient procedures, and continuous catheter technology improvements are creating sustained demand for extraction balloon systems across global healthcare markets.

 

Six Growth Hotspots Define the Next Chapter for Stone Extraction Balloons

Dual-Lumen / Multi-Lumen Balloon Systems – Leading Product Segment with Procedural Efficiency Advantage

Dual-lumen and multi-lumen extraction balloon systems accounted for an estimated 52% of the Kidney Stone Extraction Balloon Market in 2025, generating approximately USD 234 million in revenue, and are projected to grow at a CAGR of 7.1% during 2026–2032. Their market leadership is supported by the ability to combine ureteral dilation, guidewire access, balloon inflation, irrigation, and contrast delivery within a single device. This multi-function design reduces instrument exchanges, shortens procedure time, and improves control during stone extraction procedures.

 

Ureteroscopy (URS) and Retrograde Intrarenal Surgery (RIRS) – Largest Application Segment Supported by Minimally Invasive Adoption

Ureteroscopy (URS) and Retrograde Intrarenal Surgery (RIRS) form the largest application segment in the Kidney Stone Extraction Balloon Market, accounting for approximately 68% of revenue, or USD 306 million in 2025, and are projected to expand at a CAGR of 6.8% during 2026–2032. Rising use of minimally invasive endoscopic stone procedures is increasing demand for extraction balloons, which support ureteral dilation, fragment retrieval, and stone clearance during URS and RIRS, strengthening recurring procedural demand for disposable balloon-based devices in hospitals.

 

Silicone-Based Extraction Balloons – Leading Material Segment Due to Biocompatibility and Flexibility

Silicone-based extraction balloons represent the largest material segment in the Kidney Stone Extraction Balloon Market, accounting for approximately 45% of global revenue, or about USD 202.5 million in 2025. The segment is projected to expand at a CAGR of 6.4% during 2026–2032. Demand is supported by silicone’s biocompatibility, flexibility, low-friction surface, and dimensional stability, which help reduce tissue irritation and support controlled balloon inflation and deflation during minimally invasive stone-removal procedures in the ureter and renal pelvis.

 

Hospitals – Largest End User Segment Driven by Complex Stone Management Procedures

Hospitals represent the largest end-user segment in the Kidney Stone Extraction Balloon Market, accounting for approximately 62% of global revenue, or about USD 279 million in 2025. Their dominance reflects the concentration of complex stone-removal procedures, including advanced ureteroscopy and PCNL, within tertiary and multispecialty facilities. High patient throughput, access to imaging and anesthesia support, and greater procurement of multiple balloon sizes sustain recurring demand. The hospital segment is projected to expand at a CAGR of 5.8% during 2026–2032.

 

Ambulatory Surgical Centers (ASCs) – Fastest-Growing End User Segment Driven by Outpatient Urology Expansion

Ambulatory Surgical Centers represent the fastest-growing end-user segment in the Kidney Stone Extraction Balloon Market, accounting for approximately 23% share and USD 103.5 million in 2025 revenue, with a projected CAGR of 8.1% during 2026–2032. Growth is supported by rising outpatient ureteroscopy and stone-removal procedures, lower treatment costs than hospital settings, and increasing use of disposable extraction balloons. Faster patient turnover and preference for minimally invasive procedures are further strengthening device demand across standalone and physician-owned ASCs.

 

Asia-Pacific – Fastest-Growing Regional Market Driven by Rising Stone Burden and Healthcare Expansion

Asia-Pacific is the fastest-growing region in the Kidney Stone Extraction Balloon Market, accounting for approximately 25% of global revenue, equivalent to USD 112.5 million in 2025. Regional demand is increasing as hospitals and urology centers perform greater numbers of ureteroscopic and endoscopic stone-removal procedures, expanding consumption of balloon-based stone extraction devices and other single-use urology accessories. Rising kidney and ureteral stone treatment volumes, expansion of endourology services, and increasing availability of minimally invasive stone-management procedures across China, India, Japan, and Southeast Asia are strengthening device utilization. Greater procedural capacity at hospitals and specialized urology centers is expected to support an 8.2% CAGR during 2026–2032.

 

Endourology Leaders Raise the Bar for Stone Management Balloons

Boston Scientific Corporation – Broad Endourology Portfolio Supports Stone-Management Leadership

Boston Scientific is one of the major established participants in balloon-assisted urinary stone management, supported by a broad portfolio covering ureteroscopy, percutaneous nephrolithotomy (PCNL), guidewires, retrieval devices, and ureteral occlusion technologies. Its Occluder™ Occlusion Balloon Catheter is designed for temporary ureteral occlusion during endourological procedures and can help control the collecting system during kidney stone interventions. The portfolio includes 5 Fr and 7 Fr catheters with 26 Fr and 34 Fr balloon configurations and catheter lengths of 65 cm or 100 cm, allowing physicians to select configurations according to procedural requirements. Boston Scientific specifically positions occlusion balloons within its PCNL instrumentation workflow for kidney stone retrieval procedures.

Boston Scientific's overall commercial scale also strengthens its ability to distribute specialized urology consumables globally. The company generated USD 20.074 billion in total sales during 2025, up 19.9% year over year, while its MedSurg business recorded 6.5% organic growth in Q4 2025. These figures represent company-wide performance rather than kidney stone balloon revenue, but demonstrate the manufacturing, sales, and clinical-support infrastructure behind its endourology portfolio.

Becton, Dickinson and Company (BD) – High-Pressure Balloon Technology Targets Ureteral Access and Dilation

BD is another major participant through its Bard-derived stone-management portfolio, particularly the UroForce™ and X-Force™ ureteroscopic balloon dilation platforms. Its UroForce™ catheter uses multi-layer Nydex™ balloon material, Pebax™ shaft construction, radiopaque markers, and Glissando™ coating, with rated burst pressures reaching up to 23 ATM. The technology is designed to improve trackability and positioning close to a stone or ureteral lesion while providing controlled dilation.

BD's X-Force™ U30 extends this capability with a patented multilayer balloon offering a 30 ATM rated burst pressure. The dual-lumen system can track over a 0.038-inch guidewire, while its second lumen supports inflation, pressure management, or contrast delivery depending on configuration. BD generated USD 21.84 billion in fiscal 2025 revenue, an increase of 8.2% from 2024, providing significant commercial scale for its global urology and interventional device portfolio.

Other Companies and Their Role in the Market

• Cook Medical: Supplies the UPJ Occlusion Balloon Catheter for preventing stone fragments from migrating during percutaneous lithotripsy and the 65 cm Rutner Balloon Dilation Stone Extractor for ureteral dilation and stone manipulation.

• Olympus Corporation: Provides Uro-EZDilate and Nephro-EZDilate balloon systems for URS and PCNL; Uro-EZDilate is offered in 12–18 Fr sizes, while Nephro-EZDilate supports 24–30 Fr percutaneous access.

• Teleflex Incorporated: Participates through specialized stone extractors and occlusion catheters used in the treatment of ureteral and kidney stones during endourological procedures.

• AccuPath Group: Operates primarily as a specialized catheter technology and OEM supplier, offering lithotripsy balloon catheter platforms and customized balloon sizes for minimally invasive kidney stone applications.

 

Rising Stone Procedures Turn Balloons into Recurring Demand

Rising Global Stone Burden Expands the Addressable Procedure Pool

The increasing clinical burden of urolithiasis is creating a larger recurring patient base for kidney stone extraction balloons. A 2025 meta-analysis covering 22 studies and 1.28 million participants estimated global urolithiasis prevalence at 10.85%, while prevalence reached 12.93% among males and 8.91% among females. Separately, Global Burden of Disease 2021 data identified approximately 106 million new urolithiasis cases worldwide in 2021, with the absolute number of incident cases increasing 26.7% between 2000 and 2021. In the United States alone, the NIDDK reports that approximately 11% of men and 6% of women experience kidney stones during their lifetime. A larger diagnosed stone population increases the number of patients progressing to ureteroscopy, RIRS, PCNL, and other interventions where balloon catheters can be required for ureteral dilation, occlusion, access management, or stone-fragment control.

 

Ureteroscopy Gains Share as Stone Treatment Moves Toward Endoscopic Intervention

The continued shift toward endoscopic stone management directly supports demand for balloon-compatible devices used alongside ureteroscopes and guidewires. A U.S. population-based study of 8,348 PCNL patients found that ureteroscopy's share of subsequent stone procedures increased from 30.8% in 2010 to 51.8% in 2019, while shock-wave lithotripsy's share fell from 39.5% to 14.7%. This transition is commercially important because ureteroscopy creates recurring demand for disposable endourology accessories, including dilation and occlusion balloons, guidewires, access devices, and stone retrieval products. As flexible ureteroscopy and RIRS penetrate a broader range of renal and ureteral stone cases, manufacturers with integrated endourology portfolios gain opportunities to increase per-procedure device revenue.

 

Outpatient Stone Surgery Creates a Higher-Volume Device Consumption Channel

Migration of stone procedures into ambulatory settings is expanding the addressable customer base beyond conventional hospital operating rooms. An analysis of 29,433 ureteroscopy and shock-wave lithotripsy patients found that 70.8% of urinary stone procedures were performed in ambulatory settings. Adjusted surgical costs averaged approximately USD 4,746 for ambulatory cases compared with USD 10,669 for inpatient or emergency-based cases, supporting continued healthcare-system interest in outpatient treatment. Another U.S. study found that PCNL shifted from 59.9% inpatient treatment in 2010 to 85.3% outpatient treatment by 2019 among the studied commercially insured population. Higher procedural throughput in ASCs and outpatient departments favors disposable, standardized extraction and dilation devices that can streamline workflows and reduce device exchanges.

 

Stone Recurrence and Residual Fragments Generate Repeat Intervention Demand

Kidney stone disease creates repeat rather than purely one-time device demand. The European Association of Urology reports an approximately 26% five-year recurrence rate among first-time stone formers, while more than 10% of patients develop highly recurrent disease. Residual fragments further increase the potential for follow-up intervention: patients with fragments of 4 mm or smaller show intervention rates of 17–29% at approximately 49 months, while patients with residual fragments larger than 4 mm can experience intervention rates ranging from 24% to 100%. Recurring stone formation and secondary procedures increase lifetime exposure to ureteroscopy, PCNL, and associated disposable accessories, supporting repeat sales of extraction, dilation, and occlusion balloon catheters rather than demand being limited to newly diagnosed patients.

 

Analyst View: Device Versatility Shapes the Next Growth Phase

The Kidney Stone Extraction Balloon Market is expanding with the growing use of minimally invasive procedures for kidney and ureteral stone removal. Higher ureteroscopy and RIRS volumes are increasing demand for extraction balloons used to retrieve stone fragments, control fragment migration, and support efficient stone clearance. Product development is moving toward balloons with improved flexibility, controlled inflation, stronger materials, and multi-lumen designs that reduce device exchanges during procedures. Future market growth will increasingly depend on technologies that improve fragment retrieval efficiency, procedural control, and compatibility with modern endourology workflows.

 

Kidney Stone Extraction Balloon Market Report Coverage at a Glance

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 450 Million
Revenue Forecast in 2032	USD 690 Million
Overall Growth Rate	CAGR of 6.25% (2026–2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026–2032)
Segmentation	By Product Type, By Surgical Application, By Balloon Material, By End User, By Geography
By Product Type	Dual-Lumen / Multi-Lumen Extraction Balloons, Single-Lumen Balloon Systems, Double-Balloon and Specialty Occlusion Systems
By Surgical Application	Ureteroscopy (URS) and Retrograde Intrarenal Surgery (RIRS), Percutaneous Nephrolithotomy (PCNL), Other Stone Management Procedures
By Balloon Material	Silicone-Based Extraction Balloons, Polyurethane and Nylon Balloons, Other Materials
By End User	Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Urology Clinics
By Geography	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	U.S., Canada, Germany, France, Netherlands, China, India, South Korea, Japan, Brazil, Mexico, UAE, Saudi Arabia, South Africa
Market Drivers	Growing stone incidence, expanding minimally invasive treatment adoption, rising outpatient procedures, and continuous catheter technology improvements
Customization Option	Available upon request